APA (7th ed.) Citation

Jimoh, A. O., Hudu, S. A., Sabir, A. A., Adamu, A. A., Bello, N., Tahir, A., . . . Cui, H. (2026). Comparative Efficacy, Safety, and Cost‐Utility of DPP‐4 Inhibitors and Metformin Combination Therapy in Type 2 Diabetes: A Systematic Review of Real‐World Clinical and Economic Outcomes. Journal of Diabetes Research, 2026, 1. https://doi.org/10.1155/jdr/8464330

Chicago Style (17th ed.) Citation

Jimoh, Abdulgafar Olayiwola, Shuaibu Abdullahi Hudu, Anas Ahmad Sabir, Adamu Ahmed Adamu, Nura Bello, Albashir Tahir, Nura Abubakar, and Huantian Cui. "Comparative Efficacy, Safety, and Cost‐Utility of DPP‐4 Inhibitors and Metformin Combination Therapy in Type 2 Diabetes: A Systematic Review of Real‐World Clinical and Economic Outcomes." Journal of Diabetes Research 2026 (2026): 1. https://doi.org/10.1155/jdr/8464330.

MLA (9th ed.) Citation

Jimoh, Abdulgafar Olayiwola, et al. "Comparative Efficacy, Safety, and Cost‐Utility of DPP‐4 Inhibitors and Metformin Combination Therapy in Type 2 Diabetes: A Systematic Review of Real‐World Clinical and Economic Outcomes." Journal of Diabetes Research, vol. 2026, 2026, p. 1, https://doi.org/10.1155/jdr/8464330.